ICON is a global provider of outsourced drug development services to biopharma, medical device, government, biosimilar and generic organisations.
We offer a full range of clinical, consulting and commercial services that range from trial design to full study execution, and from clinical to post-market commercialisation.
Our services are supported by in-depth therapeutic and regulatory expertise and market-leading technology and analytics. We are the only full service CRO that offers the knowledge, software and systems for adaptive trials.
Address the complexities of implementation of wearable devices in trial design, execution and reporting.
Webinar: 13 October, 2017
learn about integrating evidence development and market access processes to target the same value proposition stakeholders.